Caspofungin is an antifungal drug, the first of a new class termed the echinocandins from Merck & Co., Inc. It shows activity against infections with Aspergillus and Candida, and works by inhibiting β(1,3)-D-Glucan of the fungal cell wall. Caspofungin is administered intravenously. For more information, please visit the website: https://www.creative-peptides.com/product/caspofungin-item-z10-101-157-34589.html
